Merck Acquires Novel Neurodegenerative Disease Target With Calporta Buy

 
• By Mandy Jackson
Neurodegenerative disease, neural system and memory problems concept 3d rendering. - Illustration
Merck gets a preclinical candidate for neurodegenerative diseases in Calporta deal. • Source: Shutterstock

More from Deals

More from Business